OCT 29, 2026 · JOURNAL ARTICLE
In Vivo Gene Editing of PCSK9 in the Prevention of Atherosclerotic Cardiovascular Disease: From Genetic Validation to Clinical Application
Revista Argentina De Cardiología
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide, and low-density lipoprotein cholesterol (LDL-C) is the primary causal